Bariatric and metabolic endoscopy: impact on obesity and related comorbidities

Ther Adv Gastrointest Endosc. 2021 Jun 9:14:26317745211019156. doi: 10.1177/26317745211019156. eCollection 2021 Jan-Dec.

Abstract

The global obesity pandemic is among the most significant public health crises today. Furthermore, obesity remains a major risk factor for many weight-related comorbid conditions including cardiovascular disease, type 2 diabetes mellitus, liver disease, and cancer. Endoscopic bariatric therapies are currently on the rise as a new tool in the fight against the obesity epidemic, offering patients an alternative to more invasive surgery and a more effective option than diet and lifestyle modifications. The aim of this review article is to summarize the current literature regarding endoscopic bariatric therapies and their impact on obesity and its associated metabolic complications.

Keywords: endobariatric therapy; endoscopic sleeve gastroplasty; obesity.

Publication types

  • Review